FENC FENNEC PHARMACEUTICALS INC.: institutional ownership and insider trading
112 funds reported holding $202M of FENNEC PHARMACEUTICALS INC. in their latest 13F filings; in Q2 2026 funds net bought $1.35M, with 24 new positions and 8 funds selling out; over the last 12 months insiders bought $0 and sold $11.9M on the open market.
Famous investors holding FENC
- Renaissance Technologies (Renaissance Technologies): $1.44M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $764K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $649K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $283K, 0.0% of the portfolio
Largest institutional holders of FENC
- Rosalind Advisors, Inc. — $34.3M
- AIGH Capital Management LLC — $26.7M
- Solas Capital Management, LLC — $20.3M
- BlackRock, Inc. (BLK) — $18.6M
- Sonic GP LLC — $15.2M
- AWM Investment Company, Inc. — $12.5M
- VANGUARD CAPITAL MANAGEMENT LLC — $9.02M
- VANGUARD GROUP INC — $8.22M
- Prospect Capital Advisors, LLC — $5.35M
- STATE STREET CORP (STT, STT-PG) — $4.58M
Recent FENC insider trades
- Sep 15, 2026: Brughera Marco Maria sold 15,545 shares ($160K)
- Sep 1, 2026: Raykov Rosty sold 10,000 shares ($121K)
- Aug 31, 2026: Sayad Pierre Sargis sold 12,000 shares ($146K)
- Aug 27, 2026: Andrade Robert sold 75,000 shares ($884K)
5%+ owners
- Rosalind Advisors, Inc.: 9.6% (Schedule 13G/A, filed Aug 13, 2026)
- Orin Hirschman: 7.1% (Schedule 13G/A, filed Oct 19, 2026)
- Solas Capital Management, LLC: 5.4% (Schedule 13G/A, filed Aug 14, 2026)